![]() |
|
RESÚMENES ABRIL 2009 |
Other Neuropsychiatric Disorders & General Information
(Haga un click en la
información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! - Previously Undetected Metabolic Syndromes and
Infectious Diseases Among Psychiatric Inpatients
Aileen B. Rothbard, Michael B. Blank, Jeffrey
P. Staab, Thomas TenHave,
Donald S. Young, Sheila D. Berry, and Susan Eachus
Psychiatr Serv 60:534-537, April 2009
3 - Effects
of Quetiapine on Sleep in Nonpsychiatric
and Psychiatric Conditions
Jessica N Wine, Christina Sanda, Joshua Caballero
The
Annals of Pharmacotherapy: Vol. 43, No. 4, pp. 707-713
5< - Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's
disease with neuropsychiatric features: A randomised, double-blind, exploratory
trial
S. Yancheva; R. Ihl; G. Nikolova; P. Panayotov;
S. Schlaefke; R. Hoerr;
for the GINDON Study Group
Aging & Mental
Health, Volume 13, Issue 2 March 2009, pages 183 - 190
GRATIS 3
- Delirium in elderly adults: diagnosis, prevention and treatment
Tamara G. Fong, Samir R. Tulebaev & Sharon K.
Inouye
Nature Reviews Neurology 5, 210-220 (April 2009)
3 - Incidence and outcomes of bulimia
nervosa: a nationwide population-based study
A. Keski-Rahkonen, H. W. Hoek, M.
S. Linna, A. Raevuori, E. Sihvola,
C. M. Bulik, A. Rissanen and J. Kaprio
Psychological
Medicine (2009), 39:823-831
3! - Resolving
the relationship between ApolipoproteinE and
depression
Michael A. Slifer, Eden
R. Martin, John R. Gilbert, Jonathan L. Haines and Margaret A. Pericak-Vance
Neuroscience
Letters. Volume 455, Issue 2, 15 May 2009, Pages 116-119
3 - Theta Burst Stimulation of the Prefrontal
Cortex: Safety and Impact on Cognition, Mood, and Resting Electroencephalogram
Nicola Grossheinrich, Anne Rau, Oliver Pogarell, Kristina Hennig-Fast, Maren Reinl, Susanne Karch, Alica Dieler, Gregor Leicht, Christoph Mulert, Andrea Sterr and Frank Padberg
Biological
Psychiatry.
Volume 65, Issue 9, 1 May 2009, Pages 778-784
3 - Alternative Aβ Immunotherapy Approaches for Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets,
Volume 8, Number 2, April 2009 , pp. 114-127
3 - Critical
Issues for Successful Immunotherapy in Alzheimer's Disease:
Development of Biomarkers and Methods for Early Detection and Intervention
Tarawneh, Rawan; Holtzman, David M.
CNS & Neurological Disorders - Drug Targets,
Volume 8, Number 2, April 2009 , pp. 144-159
4 - Optimal Dosing of Galantamine in Patients
with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized,
Double-Blind, Placebo-Controlled Trial.
Aronson, Stephen; Baelen, Bart Van; Kavanagh,
Shane; Schwalen, Susanne
Drugs & Aging. 26(3):231-239, 2009
3 - Bupropion and naltrexone: a review of their use individually and in
combination for the treatment of obesity
Raymond A Plodkowski, Quang Nguyen
, Umasankari Sundaram
, Loida Nguyen
, Diane L Chau & Sachiko St Jeor
Expert Opinion on Pharmacotherapy. April 2009, Vol. 10, No. 6, Pages 1069-1081
3! -
Hypoglycemic Episodes and Risk of
Dementia in Older Patients With Type
2 Diabetes Mellitus
Rachel A. Whitmer,
Andrew J. Karter, Kristine Yaffe, Charles P. Quesenberry Jr, Joseph V. Selby
3! - The prevention
of dementia
Ruth Peters
International
Journal of Geriatric Psychiatry. Volume 24 Issue
5, Pages 452 - 458
3! - Treatment with galantamine and time to nursing
home placement in Alzheimer's disease patients with and
without cerebrovascular disease
Howard H.
Feldman, Tuula Pirttila,
Jean François Dartigues,
Brian Everitt, Bart Van Baelen,
Susanne Schwalen, Shane Kavanagh
International
Journal of Geriatric Psychiatry. Volume 24 Issue
5, Pages 479 - 488
3! - Use of benzodiazepines, depressive symptoms and cognitive
function in old age
Peter van Vliet, Roos C. van der Mast, Marianne
van den Broek, Rudi G. J. Westendorp,
Anton J.M. de Craen
International
Journal of Geriatric Psychiatry. Volume 24 Issue
5, Pages 500 - 508
4 - Effects of memantine on
cognition in patients with moderate to
severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six
randomized, double-blind, placebo-controlled studies
Patrizia Mecocci, Anna Bladström, Karina Stender
International
Journal of Geriatric Psychiatry. Volume 24 Issue
5, Pages 532 - 538
3! - Powerful
beneficial effects of macrophage colony-stimulating factor on β-amyloid deposition and cognitive impairment
in Alzheimer's disease
Vincent Boissonneault,
Mohammed Filali, Martine Lessard, Jane Relton, Gordon Wong
and Serge Rivest
5< - Lamotrigine
in the treatment of binge-eating
disorder with obesity: a randomized, placebo-controlled monotherapy trial
Guerdjikova, Anna I.; McElroy, Susan L.; Welge, Jeffrey
A.; Nelson, Erik; Keck, Paul
E.; Hudson, James I.
International
Clinical Psychopharmacology:
May 2009 - Volume 24 - Issue
3 - pp 150-158
3 - What is
the effect of selective serotonin
reuptake inhibitors on temperament and character in patients with fibromyalgia?
Marianna Mazza, Osvaldo Mazza, Massimiliano Pomponi, Marco Di Nicola, Luca Padua, Massimo Vicini, Pietro Bria and Salvatore Mazza
Comprehensive Psychiatry. Volume 50, Issue
3, May-June 2009, Pages 240-244
3 - Safety and Subjective Sleep Effects of
Ramelteon Administration in
Adults and Older Adults With
Chronic Primary Insomnia: A 1-Year, Open-Label Study
Gary S. Richardson, Gary Zammit,
Sherry Wang-Weigand, and
Jeffrey Zhang
J Clin Psychiatry 2009;70(4):467-476
3 - Medically unexplained symptoms, somatisation disorder and hypochondriasis: Course and prognosis. A systematic review
Tim C. olde Hartman, Machteld
S. Borghuis, Peter L.B.J. Lucassen, Floris A. van de Laar, Anne E. Speckens and Chris van Weel
Journal of Psychosomatic Research. Volume 66, Issue
5, May 2009, Pages 363-377
3 - The relationship
between fatigue and psychiatric disorders: Evidence for the
concept of neurasthenia
Samuel B. Harvey, Simon Wessely, Diana Kuh and Matthew Hotopf
Journal of Psychosomatic Research. Volume 66, Issue
5, May 2009, Pages 445-454
5 - Efficacy and safety
of natural acetylcholinesterase
inhibitor huperzine A in the treatment of
Alzheimer’s disease: an updated meta-analysis
Bai-song Wang, Hao Wang, Zhao-hui Wei,
Yan-yan Song,
Lu Zhang and Hong-zhuan Chen
Journal
of Neural Transmission. Volume 116, Number 4 / April, 2009: 457-465
3 - A pilot study of impulsivity
and compulsivity in pathological gambling
Carlos Blanco, Marc N. Potenza, Suck Won Kim, Angela Ibáñez,
Rocco Zaninelli, Jerónimo Saiz-Ruiz and Jon E. Grant
Psychiatry
Research. Volume 167, Issues 1-2, 15 May 2009, Pages
161-168
3 - Suicidality in People Taking Antiepileptic Drugs: What is
the Evidence?
Bell, Gail S;
Mula, Marco; Sander, Josemir
W
CNS Drugs. 23(4):281-292,
2009
3! -
Benzodiazepine Use and Driving: A Meta-Analysis
Mark J. Rapoport, Krista L. Lanctôt, David L. Streiner,
Michel Bédard, Evelyn Vingilis,
Brian Murray, Ayal Schaffer,
Kenneth I. Shulman, and Nathan Herrmann
J Clin Psychiatry
April 21, 2009: e1-e11
3 - Challenges in the Search for
Drugs to Treat Central Nervous System Disorders
S.
J. Enna, and M. Williams
3! - Association of Antipsychotic Use With Hospital Events and Mortality Among
Medicare Beneficiaries Residing
in Long-Term Care Facilities
Simoni-Wastila, Linda; Ryder, Priscilla
T; Qian, Jingjing; Zuckerman, Ilene H; Shaffer, Thomas; Zhao, Lirong
American
Journal of Geriatric Psychiatry: May 2009 - Volume 17
- Issue 5 - pp 417-427
3 - A preclinical model of binge eating
elicited by yo-yo dieting and stressful exposure
to food: effect of sibutramine,
fluoxetine, topiramate, and midazolam
Carlo Cifani, Carlo Polidori,
Sergio Melotto, Roberto Ciccocioppo
and Maurizio Massi
Psychopharmacology. Volume 204, Number 1 / May, 2009: 113-125
3 - The partial
5-HT1A receptor agonist buspirone
enhances neurogenesis in the opossum (Monodelphis
domestica)
Marta Grabiec, Kris Turlejski
and Rouzanna L. Djavadian
European Neuropsychopharmacology.
Volume 19, Issue 6, June 2009, Pages
431-439
5 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients With Intermittent
Explosive Disorder
Emil F. Coccaro,
Royce J. Lee, and Richard J. Kavoussi
J Clin Psychiatry April 21, 2009: e1-e10
3 -
Metabolic links between
diabetes and Alzheimer’s disease
Pamela
A Maher and David R
Schubert
Expert Review of Neurotherapeutics.
May 2009,
Vol. 9, No. 5, Pages 617-630
3 -
Secretase inhibitors and modulators for Alzheimer’s disease treatment
Taisuke
Tomita
Expert Review of Neurotherapeutics.
May 2009,
Vol. 9, No. 5, Pages 661-679
GRATIS 3
- A Prospective Pilot
Study of Levetiracetam for Body Dysmorphic Disorder
Katharine A.
Phillips, and William Menard
CNS Spectr.
2009;14(5):252-260
3 - Cholinesterase Inhibitors and Beyond
Giancarlo Pepeu and Maria Grazia Giovannini
Current
Alzheimer Research. Volume
6, Number 2, April 2009
| Regresar a RESÚMENES ABRIL 2009 |